Laekna, Inc. (2105.HK), a global biotech company focused on developing novel therapies for metabolic and cancer diseases, is excited to announce a clinical collaboration with Eli Lilly and Company (Lilly),…
Pharmanovia, a global pharmaceutical company focused on commercializing innovative medicines and revitalizing established ones, today announced the expansion of its oncology portfolio with a new licensing agreement for catumaxomab. This…
Lobe Sciences, Ltd. (CSE: LOBE, OTCQB: LOBEF) and Alera Pharma, Inc. today announced the receipt of a second patent allowance for their Conjugated Psilocin™ technology. The patent, titled “Stable Psilocin…
Cancer Targeted Technology (CTT), a Seattle-based biotechnology company focused on cancer diagnostics and therapies, announced that the National Cancer Institute has awarded the Phase I portion ($400K) of a fast-track…
Universal Health Services (UHS) (NYSE: UHS) has been named a Champion of Board Diversity by The Forum of Executive Women, the leading women’s organization in the Greater Philadelphia Region. This…
Meridian Health Plan of Illinois, a provider of managed care services for children, families, and individuals with complex medical needs, has expanded its telehealth program with Blueberry Pediatrics. Initially launched…
Exact Sciences Corp. (NASDAQ: EXAS), a leader in cancer screening and diagnostic tests, will present three key abstracts at the American Association for Cancer Research (AACR) Special Conference on Liquid…
Care Access, a global leader in clinical research dedicated to advancing the future of medicine, is bringing its Heart & Kidney Health Screening initiative to Glendale, Arizona. The program aims…
Novotech, a full-service global contract research organization (CRO), has been honored with multiple awards at the 2024 Clinical Trials Arena Excellence Awards. These prestigious accolades recognize Novotech’s achievements in business…
Chemed Corporation (NYSE: CHE) today announced that its Board of Directors has authorized an additional $300 million for stock repurchases under the company’s existing share repurchase program. These repurchases will…
November marks American Diabetes Month®, an important time to raise awareness about diabetes and support the 1.2 million new diabetes diagnoses in the U.S. each year, along with the more…
Cencora, Inc. (NYSE: COR), a global leader in pharmaceutical solutions, today announced it has entered into a definitive agreement to acquire Retina Consultants of America (RCA), a leading management services…